Showing results (11-20 of 81) with videos related to
Sort By:
Pageof 9
American Journal of Clinical Dermatology|September 10, 2017
Small Molecule Inhibitors of the Hedgehog Pathway in the Treatment of Basal Cell Carcinoma of the SkinRebecca Danhof, Karl Lewis, Mariah BrownSeminars in Oncology|April 10, 2012
Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitorsRagini Kudchadkar, Karl Lewis, Rene GonzalezInternational Journal of Women'S Dermatology|November 9, 2019
Dermatomyositis in patients with autoimmune blistering diseasesAikaterini Patsatsi, David R Pearson, Victoria P WerthJournal of Molecular Biomarkers & Diagnosis|August 1, 2017
Fulminant Mycosis Fungoides with Tissue Eosinophilia: A Unique Presentation of Two Cases with Acro-Periorbital Ulceration and An Aggressive Clinical CourseDavid R Pearson, Mayumi Fujita, Whitney A HighCancer Control : Journal of the Moffitt Cancer Center|October 1, 2013
New targeted therapies in melanomaRagini R Kudchadkar, Rene Gonzalez, Karl LewisClinics in Dermatology|July 27, 2018
Systemic sclerosis: Current concepts of skin and systemic manifestationsDavid R Pearson, Victoria P Werth, Lisa Pappas-TafferDermatology Online Journal|February 16, 2018
Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado ExperienceBlake M Snyder, Jessica S Mounessa, Melissa Fazzari, et al.Dermatology and Therapy|June 11, 2025
Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis RegistryApril W Armstrong, Steven R Feldman, Timothy Fitzgerald, et al.Immunotherapy|November 19, 2011
Novel therapies in melanomaBenjamin Scheier, Rodabe Amaria, Karl Lewis, et al.Journal of the American Academy of Dermatology|March 6, 2020
Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of PennsylvaniaKimberly Bowerman, David R Pearson, Joyce Okawa, et al.Pageof 9